Results 131 to 140 of about 6,363 (176)
Idiopathic Multicentric Castleman Disease With Severe Eosinophilia and Diffuse Centrilobular Nodule-A Rare Case Report. [PDF]
Case Rep HematolLi X +6 more
europepmc +1 more source
Retrospective analysis of primary extranodal unicentric Castleman disease: a systematic review. [PDF]
Front Med (Lausanne)Shen J, Zeng Y, Liu Y, Xu N.
europepmc +1 more source
Castleman Disease in a Child: A Rare Cause of Persistent Cervical Lymphadenopathy. [PDF]
CureusDutta A +4 more
europepmc +1 more source
[Castleman disease with systemic manifestation: a case report]. [PDF]
Pan Afr Med JHmimsa A, Touihem N, Attifi H, Hmidi M.
europepmc +1 more source
Unicentric Castleman disease in intraparotid lymph node: a case report. [PDF]
Maxillofac Plast Reconstr SurgJeong YH, Kim JS, Lee H, Ahn KM.
europepmc +1 more source
Is "severe" idiopathic multicentric Castleman disease (iMCD)-idiopathic plasmacytic lymphadenopathy (IPL) really severe? [PDF]
HemasphereLi S +6 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Pathology of Castleman Disease
Hematology/Oncology Clinics of North America, 2018The term Castleman disease encompasses several distinct lymphoproliferative disorders with different underlying disease pathogenesis, and clinical outcomes. It includes unicentric and multicentric diseases with limited versus significant systemic symptoms, respectively.
David Wu, Megan S Lim, Elaine S Jaffé
exaly +3 more sources
Epidemiology of Castleman Disease
Hematology/Oncology Clinics of North America, 2018Castleman disease is a rare entity, including unicentric Castleman disease (UCD), human herpesvirus-8 plus Castleman disease (HHV-8+MCD), and idiopathic multicentric Castleman disease (iMCD). UCD is the most common at 16 per million person years and occurs at every age.
David Simpson
exaly +3 more sources
Current Opinion in Hematology, 2007
Castleman disease was initially described over 50 years ago as a benign localized mass of lymph nodes found primarily in the mediastinum of asymptomatic patients. Subsequently, additional types were recognized that extend the spectrum of this heterogeneous group of diseases. Optimal standard therapies have not been established. Currently, most patients
Anu, Dham, Bruce A, Peterson
openaire +4 more sources
Castleman disease was initially described over 50 years ago as a benign localized mass of lymph nodes found primarily in the mediastinum of asymptomatic patients. Subsequently, additional types were recognized that extend the spectrum of this heterogeneous group of diseases. Optimal standard therapies have not been established. Currently, most patients
Anu, Dham, Bruce A, Peterson
openaire +4 more sources
Surgical Pathology Clinics, 2019
Castleman disease (CD) is divided clinically into unicentric or multicentric type. Pathologically, CD is divided into hyaline-vascular and plasma cell variants. Unicentric CD is most common, about 75% of these cases are hyaline-vascular variant, and surgical excision is often curative.
Wei, Wang, L Jeffrey, Medeiros
openaire +2 more sources
Castleman disease (CD) is divided clinically into unicentric or multicentric type. Pathologically, CD is divided into hyaline-vascular and plasma cell variants. Unicentric CD is most common, about 75% of these cases are hyaline-vascular variant, and surgical excision is often curative.
Wei, Wang, L Jeffrey, Medeiros
openaire +2 more sources